What is PBM stock price today?

Visit our real-time dashboard for the current PBM stock price and live market data.

Is PBM stock going up or down today?

PBM stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PBM stock now?

The decision to buy PBM depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PBM a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PBM based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PBM stock overvalued or undervalued?

PBM currently trades at a P/E ratio of 0.13, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if PBM is fairly priced.

What is PBM's P/E ratio?

PBM has a price-to-earnings (P/E) ratio of 0.13, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is PBM's market cap?

PBM (Psyence Biomedical Ltd. Common Shares) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PBM's price to book ratio?

Price-to-book ratio for PBM is available on our dashboard along with other valuation metrics.

Does PBM pay dividends?

PBM does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PBM's dividend yield?

PBM does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PBM stock a good long-term investment?

PBM's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PBM's revenue growth rate?

Revenue growth data for PBM is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PBM are available on our dashboard with complete income statement analysis.

What are the risks of investing in PBM?

Key risks for PBM include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PBM compare to its competitors?

Compare PBM to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PBM's performance and positioning.

What is PBM's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PBM with bull, base, and bear case scenarios.

What do analysts say about PBM?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PBM. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PBM's next earnings report?

PBM reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PBM - Psyence Biomedical Ltd. Common Shares

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Psyence Biomedical Ltd. Common Shares

Psyence Biomedical Ltd. Common Shares (PBM) common stock

Price Chart

Loading chart...

PBM Key Statistics

Market Cap

$3.11M

P/E Ratio

0.13

How PBM Compares to Peers

PBM has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

PBM is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PBM(This stock)	$3.11M	0.1	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 18, 2026 at 6:56 AM EDT

Ready to invest in PBM?

Commission-free trading available. Affiliate links.

Upcoming Events for PBM

Dashboard

Enter a ticker to analyze